Skip to main content
Premium Trial:

Request an Annual Quote

Amersham Biosciences to Provide Customized Laboratory Workflow System to Windber

NEW YORK, Nov. 3 (GenomeWeb News) - Amersham Biosciences has signed agreement to design a customized version of its Scierra Solutions laboratory workflow system for the Windber Research Institute,   for  use in Windber's clinical breast cancer project, the company said today.

 

Windber, of Windber, Pa., has already been using Scierra systems for gene expression, sequencing, genotyping, and proteomics. The new system ads the capability of ing information on patient histories, patient samples, and pathology, and being integrated with the company's genomics and proteomics data, according to both parties.

 

"This first of a kind advanced workflow system links clinical data and pathology information collected on patient samples with data from our research laboratories resulting in a comprehensive data warehouse that is unrivalle in breast cancer research, Richard Somiari, Chief Operating/Scientific Officer at the Windber Research Institute, said in a statement."

 

The parties did not disclose the financial terms of the agreement.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.